Skip to main content
Back
Watch Compare

Sensus Healthcare, Inc.

Data quality: 100%
SRTS
Nasdaq Manufacturing Measuring & Analyzing Instruments
$4.42
$0.00 (0.00%)
Mkt Cap: 72.76 M
Price
$4.42
Mkt Cap
72.76 M
Day Range
$4.25 — $4.50
52-Week Range
$3.03 — $5.92
Volume
16,493
Open $4.44
50D / 200D Avg
$4.33
1.97% above
50D / 200D Avg
$4.05
9.18% above

Quick Summary

Key Takeaways

Revenue grew 0.40% annually over 5 years — modest growth
Earnings declined -216.13% over the past year
Generating 332,000.0 in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 34.66%
Capital efficient — spends only 0.71% of revenue on capex

Growth

Revenue Growth (5Y)
0.40%
Below sector avg (9.35%)
Revenue (1Y)-34.26%
Earnings (1Y)-216.13%
FCF Growth (3Y)N/A

Quality

Return on Equity
-14.95%
Above sector avg (-51.02%)
ROIC-15.67%
Net Margin-28.09%
Op. Margin-37.50%

Safety

Debt / Equity
N/A
Current Ratio7.38
Interest Coverage-15.09

Valuation

PE (TTM)
-9.43
Below sector avg (-1.98)
P/B Ratio1.42
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (44 peers)
Metric Stock Sector Median
P/E -9.4 -2.0
P/B 1.4 5.1
ROE % -15.0 -51.0
Net Margin % -28.1 -150.2
Rev Growth 5Y % 0.4 9.3
D/E — 0.3

ETFs Holding This Stock

AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0.01% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -34.26% Revenue Growth (3Y) 6.12%
Earnings Growth (1Y) -216.13% Earnings Growth (3Y) N/A
Revenue Growth (5Y) 0.40% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 27.48 M Net Income (TTM) -7.72 M
ROE -14.95% ROA -13.18%
Gross Margin 43.18% Operating Margin -37.50%
Net Margin -28.09% Free Cash Flow (TTM) 332,000.0
ROIC -15.67% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 7.38
Interest Coverage -15.09 Asset Turnover 0.47
Working Capital 43.40 M Tangible Book Value 51.19 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -9.43 Forward P/E N/A
P/B Ratio 1.42 P/S Ratio 2.65
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 0.46%
Market Cap 72.76 M Enterprise Value 48.31 M
Per Share
EPS (Diluted TTM) -0.47 Revenue / Share 1.67
FCF / Share 0.02 OCF / Share 0.03
EPS CAGR (1Y) -214.63% EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.71% FCF Conversion -4.30%
SBC-Adj. FCF 68,000 Growth Momentum -34.66

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 27.48 M 41.81 M 24.41 M 44.53 M 27.04 M
Net Income -7.72 M 6.65 M 485,000.0 24.24 M 4.12 M
EPS (Diluted) -0.47 0.41 0.03 1.46 0.25
Gross Profit 11.87 M 24.43 M 14.06 M 29.63 M 16.99 M
Operating Income -10.31 M 8.09 M -382,000.0 14.83 M 4.12 M
EBITDA — — — — —
R&D Expenses 7.78 M 4.22 M 3.68 M 3.46 M 3.44 M
SG&A Expenses 7.87 M 7.15 M — — —
D&A 400,000.0 239,000.0 275,000.0 315,000.0 613,000.0
Interest Expense 683,000.0 -932,000.0 -992,000.0 2,000.0 2,000.0
Income Tax -1.91 M 2.38 M 167,000.0 3.75 M —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 53.04 M 62.17 M 53.71 M 56.74 M 32.24 M
Total Liabilities 4.94 M 6.34 M 4.87 M 8.67 M 6.23 M
Shareholders' Equity 48.10 M 55.83 M 48.84 M 48.07 M 26.02 M
Total Debt — — — — —
Cash & Equivalents 22.08 M 22.06 M 23.15 M 25.52 M 14.52 M
Current Assets 45.89 M 56.74 M 49.53 M 53.24 M 31.25 M
Current Liabilities 4.72 M 5.89 M 4.21 M 7.70 M 5.96 M